富士製薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/19 | 1,226 | 1,238 | 1,221 | 1,223 | -1 | -0.1% | 31,400 |
2021/01/18 | 1,220 | 1,230 | 1,213 | 1,224 | -11 | -0.9% | 33,600 |
2021/01/15 | 1,230 | 1,250 | 1,229 | 1,235 | -7 | -0.6% | 51,900 |
2021/01/14 | 1,240 | 1,242 | 1,231 | 1,242 | -1 | -0.1% | 27,300 |
2021/01/13 | 1,252 | 1,252 | 1,227 | 1,243 | -8 | -0.6% | 31,900 |
2021/01/12 | 1,235 | 1,273 | 1,235 | 1,251 | +25 | +2% | 64,200 |
2021/01/08 | 1,213 | 1,230 | 1,211 | 1,226 | +8 | +0.7% | 57,100 |
2021/01/07 | 1,214 | 1,218 | 1,209 | 1,218 | +13 | +1.1% | 24,800 |
2021/01/06 | 1,207 | 1,221 | 1,205 | 1,205 | -5 | -0.4% | 31,000 |
2021/01/05 | 1,220 | 1,227 | 1,209 | 1,210 | -6 | -0.5% | 34,700 |
2021/01/04 | 1,233 | 1,233 | 1,206 | 1,216 | -28 | -2.3% | 55,000 |
2020/12/30 | 1,237 | 1,248 | 1,221 | 1,244 | -1 | -0.1% | 40,700 |
2020/12/29 | 1,208 | 1,255 | 1,208 | 1,245 | +37 | +3.1% | 59,400 |
2020/12/28 | 1,216 | 1,219 | 1,198 | 1,208 | -8 | -0.7% | 55,800 |
2020/12/25 | 1,220 | 1,228 | 1,214 | 1,216 | -7 | -0.6% | 26,200 |
2020/12/24 | 1,227 | 1,228 | 1,209 | 1,223 | -1 | -0.1% | 35,500 |
2020/12/23 | 1,225 | 1,249 | 1,219 | 1,224 | -10 | -0.8% | 35,100 |
2020/12/22 | 1,226 | 1,239 | 1,209 | 1,234 | -4 | -0.3% | 55,300 |
2020/12/21 | 1,246 | 1,256 | 1,233 | 1,238 | -6 | -0.5% | 46,500 |
2020/12/18 | 1,242 | 1,252 | 1,221 | 1,244 | +1 | +0.1% | 54,600 |
2020/12/17 | 1,271 | 1,271 | 1,227 | 1,243 | -30 | -2.4% | 102,900 |
2020/12/16 | 1,277 | 1,278 | 1,257 | 1,273 | +1 | +0.1% | 36,300 |
2020/12/15 | 1,287 | 1,287 | 1,264 | 1,272 | -15 | -1.2% | 52,300 |
2020/12/14 | 1,256 | 1,294 | 1,256 | 1,287 | +31 | +2.5% | 73,900 |
2020/12/11 | 1,264 | 1,270 | 1,253 | 1,256 | -14 | -1.1% | 42,000 |
2020/12/10 | 1,246 | 1,276 | 1,245 | 1,270 | +19 | +1.5% | 41,000 |
2020/12/09 | 1,255 | 1,255 | 1,233 | 1,251 | -4 | -0.3% | 33,100 |
2020/12/08 | 1,275 | 1,275 | 1,246 | 1,255 | -20 | -1.6% | 30,000 |
2020/12/07 | 1,275 | 1,290 | 1,266 | 1,275 | +15 | +1.2% | 65,100 |
2020/12/04 | 1,240 | 1,271 | 1,237 | 1,260 | +16 | +1.3% | 67,900 |
2020/12/03 | 1,224 | 1,249 | 1,216 | 1,244 | +19 | +1.6% | 51,900 |
2020/12/02 | 1,252 | 1,254 | 1,213 | 1,225 | -27 | -2.2% | 106,500 |
2020/12/01 | 1,243 | 1,269 | 1,238 | 1,252 | +4 | +0.3% | 112,200 |
2020/11/30 | 1,249 | 1,250 | 1,227 | 1,248 | +8 | +0.6% | 108,400 |
2020/11/27 | 1,221 | 1,244 | 1,214 | 1,240 | +26 | +2.1% | 76,400 |
2020/11/26 | 1,201 | 1,216 | 1,191 | 1,214 | +13 | +1.1% | 38,500 |
2020/11/25 | 1,220 | 1,234 | 1,201 | 1,201 | -16 | -1.3% | 65,800 |
2020/11/24 | 1,215 | 1,237 | 1,211 | 1,217 | +13 | +1.1% | 65,900 |
2020/11/20 | 1,215 | 1,215 | 1,196 | 1,204 | -16 | -1.3% | 49,100 |
2020/11/19 | 1,214 | 1,221 | 1,195 | 1,220 | +5 | +0.4% | 38,900 |
2020/11/18 | 1,250 | 1,250 | 1,214 | 1,215 | -43 | -3.4% | 54,300 |
2020/11/17 | 1,249 | 1,274 | 1,220 | 1,258 | +12 | +1% | 85,800 |
2020/11/16 | 1,250 | 1,253 | 1,230 | 1,246 | +8 | +0.6% | 46,300 |
2020/11/13 | 1,251 | 1,251 | 1,225 | 1,238 | -22 | -1.7% | 44,700 |
2020/11/12 | 1,270 | 1,277 | 1,246 | 1,260 | -6 | -0.5% | 69,200 |
2020/11/11 | 1,259 | 1,266 | 1,235 | 1,266 | +22 | +1.8% | 59,600 |
2020/11/10 | 1,262 | 1,262 | 1,230 | 1,244 | -14 | -1.1% | 75,500 |
2020/11/09 | 1,274 | 1,276 | 1,241 | 1,258 | -12 | -0.9% | 103,300 |
2020/11/06 | 1,199 | 1,270 | 1,168 | 1,270 | +78 | +6.5% | 231,200 |
2020/11/05 | 1,192 | 1,215 | 1,172 | 1,192 | +10 | +0.8% | 153,800 |
1051~
1100
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
富士製薬 | 135,700円 | +15.7% | +5.3% | 3.35% | 9.81倍 | 0.72倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
タウンズ | 49,800円 | +4.6% | +6.1% | 5.62% | 8.48倍 | 3.13倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
生化学 | 69,200円 | +9.2% | +39.0% | 4.34% | 22.90倍 | 0.50倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
ダイト | 210,200円 | +4.5% | -33.7% | 3.33% | 21.02倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 31,000円 | +150.0% | - | 0.00% | - | 15.25倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム